Sonim(SONM) - 2025 Q2 - Quarterly Results
2025-08-08 21:15
Sonim Poised for Growth in the Second Half of 2025 with Tier-One Carrier Launches Q2 Results Reflect Investments, Product Launches, and Progress on Social Mobile's Acquisition of Sonim San Diego – August 8, 2025 – Sonim Technologies, Inc. (Nasdaq: SONM), a leading provider of rugged mobile solutions for first responders, government, and enterprise, today announced its financial results for the second quarter ended June 30, 2025. "The second quarter of 2025 marked a pivotal period for Sonim as we laid the gr ...
AudioEye(AEYE) - 2025 Q2 - Quarterly Report
2025-08-08 21:11
PART I: FINANCIAL INFORMATION [Item 1. Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) Unaudited consolidated financial statements for June 30, 2025, show increased assets and liabilities, decreased equity, and improved operational performance with revenue growth and a narrowed net loss [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) As of June 30, 2025, total assets increased to **$33.9 million**, liabilities to **$26.6 million** due to a new term loan, while stockholders' equity decreased to **$7.3 million** Consolidated Balance Sheet Highlights (in thousands) | Account | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Assets** | **$33,900** | **$29,766** | | Cash and cash equivalents | $6,869 | $5,651 | | Intangible assets, net | $11,929 | $10,276 | | **Total Liabilities** | **$26,551** | **$20,330** | | Term loan, net | $12,765 | $6,820 | | Deferred revenue | $8,229 | $7,518 | | **Total Stockholders' Equity** | **$7,349** | **$9,436** | [Consolidated Statements of Operations](index=5&type=section&id=Consolidated%20Statements%20of%20Operations) Q2 2025 revenue grew **16%** to **$9.9 million**, achieving operating income of **$242,000** and a near breakeven net loss of **($2,000)**, significantly improving from Q2 2024 Q2 2025 vs Q2 2024 Performance (in thousands, except per share data) | Metric | Q2 2025 | Q2 2024 | Change (%) | | :--- | :--- | :--- | :--- | | Revenue | $9,857 | $8,470 | +16.4% | | Gross Profit | $7,619 | $6,706 | +13.6% | | Operating Income (Loss) | $242 | $(497) | +148.7% | | Net Loss | $(2) | $(735) | +99.7% | | Net Loss Per Share | $0.00 | $(0.06) | +100.0% | H1 2025 vs H1 2024 Performance (in thousands, except per share data) | Metric | H1 2025 | H1 2024 | Change (%) | | :--- | :--- | :--- | :--- | | Revenue | $19,590 | $16,553 | +18.3% | | Gross Profit | $15,357 | $13,028 | +17.9% | | Operating Loss | $(698) | $(1,128) | +38.1% | | Net Loss | $(1,471) | $(1,564) | +6.0% | | Net Loss Per Share | $(0.12) | $(0.13) | +7.7% | [Consolidated Statements of Cash Flows](index=7&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) For H1 2025, operating cash flow increased to **$1.2 million**, investing cash use rose to **$2.7 million** due to acquisitions, and financing cash flow reversed to a **$2.7 million** inflow from new debt Cash Flow Summary for Six Months Ended June 30 (in thousands) | Activity | 2025 | 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $1,171 | $613 | | Net cash used in investing activities | $(2,671) | $(1,035) | | Net cash provided by (used in) financing activities | $2,718 | $(3,728) | | **Net increase (decrease) in cash** | **$1,218** | **$(4,150)** | [Notes to Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Notes detail revenue streams, Q2 2025 asset acquisition, a new **$20 million** credit facility replacing prior debt, and the initiation of a share repurchase program - Revenue is disaggregated into two sales channels: Partner and Marketplace, and Enterprise. For the six months ended June 30, 2025, Enterprise revenue grew **27%** YoY, while Partner and Marketplace revenue grew **13%** YoY[30](index=30&type=chunk)[123](index=123&type=chunk) - One customer accounted for approximately **14%** of total revenue in the first six months of 2025 and **11%** of total accounts receivable as of June 30, 2025[32](index=32&type=chunk)[35](index=35&type=chunk) - In Q2 2025, the company completed an asset acquisition, recognizing **$1.8 million** in customer relationships, which will be amortized over 8 years[76](index=76&type=chunk) - On March 31, 2025, the company entered a new credit facility with Western Alliance Bank for up to **$20.0 million** and used proceeds to repay its previous **$7.0 million** term loan with SG Credit Partners, recognizing a **$300,000** loss on extinguishment of debt[87](index=87&type=chunk)[97](index=97&type=chunk) - In January 2025, the Board authorized a share repurchase program of up to **$12.5 million**. As of June 30, 2025, the company had repurchased shares for **$1.76 million**, with **$10.74 million** remaining[57](index=57&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=29&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses **18%** H1 2025 revenue growth, **14%** ARR increase to **$38.2 million**, rising operating expenses due to litigation, and improved liquidity from a new credit facility [Executive Overview and Key Metrics](index=30&type=section&id=Executive%20Overview%20and%20Key%20Metrics) The company achieved **18%** H1 2025 revenue growth, with ARR increasing **14%** to **$38.2 million**, despite a **1%** customer count decrease due to contract renegotiation - Annual Recurring Revenue (ARR) was approximately **$38.2 million** as of June 30, 2025, a **14%** increase year-over-year[112](index=112&type=chunk)[142](index=142&type=chunk) - The customer count decreased by **1%** to approximately **120,000** from June 30, 2024, due to a contract renegotiation within the Partner and Marketplace channel[113](index=113&type=chunk) - For the six months ended June 30, 2025, the Partner and Marketplace channel revenue grew **13%** and the Enterprise channel revenue grew **27%** over the prior year period[114](index=114&type=chunk) [Results of Operations Analysis](index=32&type=section&id=Results%20of%20Operations%20Analysis) H1 2025 revenue grew **18%** to **$19.6 million**, with gross profit matching; operating expenses rose **13%** due to increased selling, marketing, and G&A costs, partially offset by a **$1.3 million** non-cash gain Revenue by Channel - Six Months Ended June 30 (in thousands) | Channel | 2025 | 2024 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Partner and Marketplace | $10,919 | $9,704 | $1,215 | 13% | | Enterprise | $8,671 | $6,849 | $1,822 | 27% | | **Total revenue** | **$19,590** | **$16,553** | **$3,037** | **18%** | - Selling and marketing expenses for H1 2025 increased by **26%** YoY, primarily due to higher third-party marketing expenses and costs from acquisitions[129](index=129&type=chunk)[130](index=130&type=chunk) - General and administrative expenses for H1 2025 increased by **33%** YoY, mainly due to an **$830,000** increase in litigation expense, higher personnel costs, and amortization[133](index=133&type=chunk)[135](index=135&type=chunk) - A non-cash gain of **$1.31 million** was recognized in H1 2025 due to a reduction in the estimated earnout payable for the ADA Site Compliance acquisition[136](index=136&type=chunk)[137](index=137&type=chunk) [Liquidity and Capital Resources](index=36&type=section&id=Liquidity%20and%20Capital%20Resources) As of June 30, 2025, the company held **$6.9 million** in cash and **$1.4 million** in working capital, an improvement driven by **$13.4 million** in new term loan advances, ensuring sufficient liquidity for the next twelve months - Working capital increased from **$549,000** at Dec 31, 2024, to **$1,384,000** at June 30, 2025, mainly due to new debt financing[143](index=143&type=chunk) - The company initiated a **$12.5 million** share repurchase program in January 2025 and used **$1.76 million** of it in the first six months of the year[144](index=144&type=chunk) - Cash from financing activities increased significantly due to **$13.4 million** in proceeds from a new term loan, partially offset by the repayment of a **$7.0 million** previous loan[149](index=149&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=37&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section is indicated as not applicable - Not applicable[152](index=152&type=chunk) [Item 4. Controls and Procedures](index=37&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded the company's disclosure controls and procedures were effective as of June 30, 2025, with no material changes to internal control over financial reporting during the quarter - Based on an evaluation as of the end of the period, the Chief Executive Officer and Chief Financial Officer concluded that the company's disclosure controls and procedures were effective[155](index=155&type=chunk) - No material changes were made to the company's internal control over financial reporting during the quarter ended June 30, 2025[156](index=156&type=chunk) PART II: OTHER INFORMATION [Item 1. Legal Proceedings](index=40&type=section&id=Item%201.%20Legal%20Proceedings) The company is not currently involved in any legal proceedings expected to materially adversely affect its financial position or operations - Management believes the resolution of any routine disputes incidental to business operations is not likely to have a material adverse effect on the company[162](index=162&type=chunk) [Item 1A. Risk Factors](index=40&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred to the risk factors previously disclosed in the 2024 Form 10-K - No material changes to the risk factors set forth in the 2024 Form 10-K have occurred[163](index=163&type=chunk) [Item 2. Issuer Purchases of Equity Securities](index=40&type=section&id=Item%202.%20Issuer%20Purchases%20of%20Equity%20Securities) During Q2 2025, the company repurchased **143,939** shares for approximately **$1.76 million** under its **$12.5 million** share repurchase program Share Repurchases for Q2 2025 | Period | Total Shares Purchased (Program) | Average Price Paid per Share | Approx. Value Remaining ($) | | :--- | :--- | :--- | :--- | | May 1 - May 31 | 123,939 | $12.24 | $10,983,000 | | June 1 - June 30 | 20,000 | $12.38 | $10,735,000 | | **Total Q2** | **143,939** | **$12.26** | **$10,735,000** | [Item 6. Exhibits](index=41&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including officer certifications and documents related to loan modification and board resolutions
Identiv(INVE) - 2025 Q2 - Quarterly Report
2025-08-08 21:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 000-29440 DELAWARE 77-0444317 (State or other jurisdiction of incorporation or organization) 1900-B Carnegie Avenue Sa ...
Hudson Global(HSON) - 2025 Q2 - Quarterly Report
2025-08-08 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 | FORM 10-Q | | --- | | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ☒ | | OF 1934 | | For the quarterly period ended June 30, 2025 or | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT | | ☐ OF 1934 | | For the transition period from to | | Commission file number: 001-38704 | | HUDSON GLOBAL, INC. | | (Exact name of registrant as specified in its charter) | | Delawar ...
Plains GP (PAGP) - 2025 Q2 - Quarterly Report
2025-08-08 21:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________ FORM 10-Q ________________________________________________________________________________________________________________________________ ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A ...
Avalon(AWX) - 2025 Q2 - Quarterly Report
2025-08-08 21:05
2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _______________ to ________________ Commission file number 1-14105 AVALON HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) | | | (State or ot ...
Simpson(SSD) - 2025 Q2 - Quarterly Report
2025-08-08 21:04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-13429 Simpson Manufacturing Co., Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of inco ...
Plains All American Pipeline(PAA) - 2025 Q2 - Quarterly Report
2025-08-08 21:04
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________ FORM 10-Q ________________________________________________________________________________________________________________________________ ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A ...
X4 Pharmaceuticals(XFOR) - 2025 Q2 - Quarterly Report
2025-08-08 21:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition ...
Cumberland Pharmaceuticals(CPIX) - 2025 Q2 - Quarterly Report
2025-08-08 21:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Tennessee 62-1765329 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 1600 West End Avenue, Suite 1300, Nash ...